Enlivex Therapeutics Ltd

NASDAQ:ENLV   3:59:52 PM EDT
6.68
-0.10 (-1.48%)
Earnings Announcements

Enlivex Therapeutics Ltd Says Qtrly Net Loss $3.4 Mln

Published: 11/22/2021 13:26 GMT
Enlivex Therapeutics Ltd (ENLV) - Enlivex Therapeutics Ltd - Qtrly Net Loss Was $3.4 Million .
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update.
Enlivex Therapeutics Ltd - Existing Cash, Cash Equivalents Will Be Sufficient to Fund Operating Expenses, Capital Expenditure Through Year-end 2023.
Further Company Coverage: Enlv.
Ta.
((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.